ICARES Medicus, Inc. (TPEX:6612)
84.00
+0.10 (0.12%)
Dec 5, 2025, 1:28 PM CST
ICARES Medicus Market Cap
ICARES Medicus has a market cap or net worth of 3.98 billion as of December 5, 2025. Its market cap has decreased by -33.53% in one year.
Market Cap
3.98B
Enterprise Value
4.18B
Revenue
1.09B
Ranking
n/a
PE Ratio
62.58
Stock Price
84.00
Market Cap Chart
Since December 27, 2016, ICARES Medicus's market cap has increased from 1.51B to 3.98B, an increase of 162.72%. That is a compound annual growth rate of 11.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.98B | -24.59% |
| Dec 31, 2024 | 5.28B | 6.98% |
| Dec 29, 2023 | 4.93B | 77.87% |
| Dec 30, 2022 | 2.77B | 18.70% |
| Dec 30, 2021 | 2.34B | 11.21% |
| Dec 31, 2020 | 2.10B | -28.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 259.78B |
| PharmaEssentia | 189.73B |
| Heron Neutron Medical | 95.61B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Lin BioScience | 34.45B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 32.34B |